Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of metabolic phenotype and alcohol consumption on mortality risk in metabolic dysfunction-associated fatty liver disease: a population-based cohort study.

Scientific reports - 3 Jun 2024

Charatcharoenwitthaya Phunchai, Karaketklang Khemajira, Aekplakorn Wichai

Abstract excerpt

Patients with metabolic dysfunction-associated fatty liver disease (MAFLD) often present with concomitant metabolic dysregulation and alcohol consumption, potentially leading to distinct clinical outcomes. We analyzed data from 8043 participants with MAFLD in the Thai National Health Examination Survey with linked mortality records. According to the MAFLD criteria, 1432 individuals (17.2%) were categorized as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alcohol Drinking

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Metabolic Diseases

Share to Obesity

Share to Proportional Hazards Models

Share to Risk Factors

Share to Thailand

Source

Open in PubMed Open full text

Identifiers

PMID: 38830939
DOI: 10.1038/s41598-024-63453-6
PMCID: PMC11148152

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of metabolic phenotype and alcohol consumption on mortality risk in metabolic dysfunction-associated fatty liver disease: a population-based cohort study.PMID 38830939Read ↗

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated alcohol‑related liver disease represent distinct clinical phenotypes and fibrosis risks: insights from a population-based Polish cohort.Semantic proximity Read ↗

Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population.Semantic proximity Read ↗

The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants.Semantic proximity Read ↗

Association between obesity phenotypes and non-alcoholic fatty liver: a large population- based study.Semantic proximity Read ↗

Predictive value of the triglyceride-glucose index for metabolic-associated fatty liver disease in individuals with different metabolic obese phenotypesSemantic proximity Read ↗

Evaluation of Liver Metabolism Biomarkers in Metabolic Associated Fatty Liver Disease According to Obesity Phenotype.Semantic proximity Read ↗

Joint effect of BMI and metabolic status on mortality among adults: a population-based longitudinal study in United States.Semantic proximity Read ↗

[Precise clinical classification of metabolic associated fatty liver disease].Semantic proximity Read ↗

FTO Polymorphisms are Associated with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Susceptibility in the Older Chinese Han Population.Semantic proximity Read ↗

Common Pathogenetic Pathways of Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes MellitusSemantic proximity Read ↗

Alcohol-driven phenotypic transition in MASLD and risk of liver-related events.Semantic proximity Read ↗

Genome-wide association study of metabolic dysfunction-associated fatty liver disease in a Korean population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.